DICE Therapeutics Q2 EPS $(0.58)

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.

Total
0
Shares
Related Posts